LZ

Linping Zhang

President & CEO, Head of R&D, Archimmune Therapeutics

Greater Boston

Investor
VC

Invests in

Stages:

Seed
Pre-seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Drug Discovery
Biotechnology
Pharmaceutical Industry
Clinical Development
Drug Development
Lifesciences
Oncology
Technology Transfer
Clinical Trials
GCP
R&D
Biochemistry
Chromatography
Biopharmaceuticals
Commercialization
Organic Chemistry
CTMS
Molecular Biology
Protein Chemistry
Life Sciences

Education

Work Experience

Archimmune Therapeutics Inc.

2023

  • President & CEO, Head of R&D

    2023

Fosun Pharma USA Inc.

2022

  • Senior Vice President, Early Development

    2022

Alere Advisors

2018 - 2022

  • Principal & co-founder

    2018 - 2022

6 Dimensions Capital

2018 - 2020

  • Venture Partner

    2018 - 2020

BioMed Valley Discoveries, Inc.

2010 - 2018

  • Executive Director, Translational Sciences | Head of Clinical Development

    2010 - 2018

Novartis Institutes for Biomedical Research, Inc.

2007 - 2010

  • Associate Director, Project & Portfolio Management

    2007 - 2010

Infinity Pharmaceuticals, Inc

2001 - 2006

  • Founding Scientist, Project Leader

    2001 - 2006

Harvard University

2000 - 2001

  • Postdoctoral Fellow

    2000 - 2001

Guangdong Institute of Materia Medica

1990 - 1995

  • Sr. Principal Investigator

    1990 - 1995